These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7160439)

  • 1. Serotonin modulates the dissociation of [3H]imipramine from human platelet recognition sites.
    Wennogle LP; Meyerson LR
    Eur J Pharmacol; 1982 Dec; 86(2):303-7. PubMed ID: 7160439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
    Plenge P; Mellerup ET
    Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.
    Wennogle LP; Meyerson LR
    Life Sci; 1985 Apr; 36(16):1541-50. PubMed ID: 3982224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter.
    Humphreys CJ; Beidler D; Rudnick G
    Biochem Soc Trans; 1991 Feb; 19(1):95-8. PubMed ID: 2037207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]-5-methoxytryptoline is not actively accumulated by rabbit platelets.
    Segonzac A; Schoemaker H; Lee CR; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):1-4. PubMed ID: 3627287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity [3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa.
    Weizman R; Carmi M; Tyano S; Apter A; Rehavi M
    Life Sci; 1986 Mar; 38(13):1235-42. PubMed ID: 3959752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.
    Paul SM; Rehavi M; Skolnick P; Goodwin FK
    Life Sci; 1980 Mar; 26(12):953-9. PubMed ID: 6104760
    [No Abstract]   [Full Text] [Related]  

  • 12. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.
    Suranyi-Cadotte BE; Quirion R; Nair NP; Lafaille F; Schwartz G
    Life Sci; 1985 Feb; 36(8):795-9. PubMed ID: 3974410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 14. Interrelationship between blood serotonin levels and affinity of platelet imipramine binding sites in healthy subjects.
    Meyer-Lindenberg A; Rao ML
    Pharmacopsychiatry; 1993 Jan; 26(1):15-9. PubMed ID: 8378407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced 3H-imipramine binding but unaltered 3H-serotonin uptake in platelets of adolescent enuretics.
    Weizman R; Carmi M; Tyano S; Rehavi M
    Psychiatry Res; 1986 Sep; 19(1):37-42. PubMed ID: 3786597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
    O'Riordan C; Phillips OM; Williams DC
    J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic properties of [3H]2-nitroimipramine binding to human platelets.
    Davis A
    Eur J Pharmacol; 1983 Dec; 96(1-2):105-10. PubMed ID: 6662191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.